Fred VanVleet and Houston see off Golden State to force deciding Game 7
China ‘evaluating’ US offer to engage in trade negotiations
EU microchip strategy ‘deeply disconnected from reality’, say official auditors
Aston Martin limits exports to US because of Trump tariffs
Liberal-aligned thinktank running anti-Greens ads received $600,000 from coal industry in Queensland election
Fred VanVleet and Houston see off Golden State to force deciding Game 7
China ‘evaluating’ US offer to engage in trade negotiations
EU microchip strategy ‘deeply disconnected from reality’, say official auditors
Aston Martin limits exports to US because of Trump tariffs
Liberal-aligned thinktank running anti-Greens ads received $600,000 from coal industry in Queensland election
MHRA authorises uses of Casgevy as a potential cure for sickle cell disease and beta thalassemia
Britain’s drugs regulator has approved a groundbreaking treatment for two painful and debilitating lifelong blood disorders, which works by “editing” the gene that causes them.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for Casgevy to be used to treat sickle cell disease and beta thalassemia.
Notifications
More Stories
Scientists record seismic tremors from title-clinching Liverpool win over Spurs
Measles outbreak: how contagious is it and what are the symptoms?
Ronan the head-bobbing sea lion proves animals can keep a beat: ‘No human was better’